Table of Contents Author Guidelines Submit a Manuscript
Interdisciplinary Perspectives on Infectious Diseases
Volume 2016, Article ID 9171395, 4 pages
http://dx.doi.org/10.1155/2016/9171395
Research Article

Evaluation of Antimicrobial Resistance in Staphylococcus aureus Isolates by Years

1Faculty of Medicine, Department of Medical Microbiology, Yuzuncu Yil University, 65080 Van, Turkey
2Faculty of Medicine, Department of Pediatric Diseases, Yuzuncu Yil University, 65080 Van, Turkey

Received 10 January 2016; Revised 24 March 2016; Accepted 14 April 2016

Academic Editor: Peter A. C. Maple

Copyright © 2016 Cennet Rağbetli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. J. Ryan and C. G. Ray, “Staphylococci,” in Sherris Medical Microbiology, pp. 429–442, The McGraw-Hill Companies, New York, NY, USA, 5th edition, 2010. View at Google Scholar
  2. P. R. Murray, K. S. Rosenthal, and M. A. Pfaller, “Staphylococcus and related organisms,” in Medical Microbiology, pp. 221–236, Mosby, St. Louis, Mo, USA, 5th edition, 2005. View at Google Scholar
  3. C. J. Ioannou, G. W. Hanlon, and S. P. Denyer, “Action of disinfectant quaternary ammonium compounds against Staphylococcus aureus,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 1, pp. 296–306, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. N. van de Sande-Bruinsma, H. Grundmann, D. Verloo et al., “Antimicrobial drug use and resistance in Europe,” Emerging Infectious Diseases, vol. 14, no. 11, pp. 1722–1730, 2008. View at Publisher · View at Google Scholar
  5. Z. Koçak Tufan, H. Irmak, C. Bulut, S. Cesur, S. Kinikli, and A. P. Demlröz, “The effectiveness of hand hygiene products on MRSA colonization of health care workers by using CHROMagar MRSA,” Mikrobiyoloji Bulteni, vol. 46, no. 2, pp. 236–246, 2012. View at Google Scholar · View at Scopus
  6. A. Gleeson, P. Larkin, C. Walsh, and N. OSullivan, “Methicillin-resistant Staphylococcus aureus: Prevalence, incidence, risk factors, and effects on survival of patients in a specialist palliative care unit: a prospective observational study,” Palliative Medicine, vol. 30, no. 4, pp. 374–381, 2016. View at Publisher · View at Google Scholar
  7. A. Robicsek, J. L. Beaumont, S. M. Paule et al., “Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals,” Annals of Internal Medicine, vol. 148, no. 6, pp. 409–418, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Cardo, T. Horan, M. Andrus et al., “A report from the NNIS system (CDC). National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004,” American Journal of Infection Control, vol. 32, no. 8, pp. 470–485, 1992. View at Google Scholar
  9. Clinical and Laboratory Standards Institute, “Performance standards for antimicrobial susceptibility testing: twenty-fourth informational supplement,” Tech. Rep. M100-S24, CLSI, Wayne, Pa, USA, 2014. View at Google Scholar
  10. R. J. Gordon and F. D. Lowy, “Pathogenesis of methicillin-resistant Staphylococcus aureus infection,” Clinical Infectious Diseases, vol. 46, no. 5, pp. S350–S359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. D. J. Diekema, M. A. Pfaller, F. J. Schmitz et al., “Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999,” Clinical Infectious Diseases, vol. 32, pp. 114–132, 2001. View at Google Scholar
  12. E. W. Tiemersma, S. L. A. M. Bronzwaer, O. Lyytikäinen et al., “Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002,” Emerging Infectious Diseases, vol. 10, no. 9, pp. 1627–1634, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. W. R. Jarvis, J. Schlosser, R. Y. Chinn, S. Tweeten, and M. Jackson, “National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US health care facilities, 2006,” American Journal of Infection Control, vol. 35, no. 10, pp. 631–637, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Cıtak and E. Karacocuk, “Antibiotic susceptibility of methicillin-resistant Staphylococcus aureus strains in hospital and community-acquired,” Çukurova Üniversitesi Tıp Fakültesi Dergisi, vol. 26, no. 1, pp. 13–17, 2004. View at Google Scholar
  15. S. Yilmaz, A. Kiliç, A. Karagöz, O. Bedir, A. Ü. Güçlü, and A. C. Başustaoģlu, “Investigation of various virulence factors among the hospital and community-acquired Staphylococcus aureus isolates by Real-Time PCR method,” Mikrobiyoloji Bulteni, vol. 46, no. 4, pp. 532–545, 2012. View at Google Scholar · View at Scopus
  16. T. Haznedaroglu, O. Oncul, T. Hosbul, S. Cavuşlu, O. Baylan, and M. Ozyurt, “Methicillin resistance in Staphylococcus aureus strains isolated from hospitalized patients: three-year trend,” TAF Preventive Medicine Bulletin, vol. 9, no. 6, pp. 585–590, 2010. View at Google Scholar
  17. N. Aydin, B. Gultekin, M. Eyigor, and M. Gurel, “The antibiotic resıstance of Staphylococci isolated of clinical specimens,” Adnan Menderes Üniversitesi Tıp Fakültesi Dergisi, vol. 2, no. 3, pp. 21–26, 2001. View at Google Scholar
  18. B. Ozkalp and H. Baybek, “In vitro susceptibility to various antibiotics of Staphylococcus aureus isolated from clinical specimens,” Genel Tip Derg, vol. 13, no. 2, pp. 65–68, 2003. View at Google Scholar
  19. K. Hiramatsu, H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F. C. Tenover, “Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility,” Journal of Antimicrobial Chemotherapy, vol. 40, no. 1, pp. 135–136, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Hiramatsu, N. Aritaka, H. Hanaki et al., “Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin,” The Lancet, vol. 350, no. 9092, pp. 1670–1673, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Nakipoglu, S. Derbentli, A. A. Cagatay, and H. Katranci, “Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospital,” BMC Infectious Diseases, vol. 5, article 31, 2005. View at Publisher · View at Google Scholar
  22. N. C. Gursoy, Y. Ersoy, S. Gunal, and Ç. Kuzucu, “Antibiotic resistance in Staphylococcus aureus strains isolated from blood cultures,” Ankem Dergisi, vol. 23, no. 1, pp. 26–29, 2009. View at Google Scholar
  23. R. N. Jones, T. R. Fritsche, H. S. Sader, and J. E. Ross, “LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers),” Diagnostic Microbiology and Infectious Disease, vol. 59, no. 3, pp. 309–317, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Adaleti, Y. Nakipoglu, N. Ceran, C. Tasdemir, F. Kaya, and S. Tasdemir, “Prevalence of phenotypic resistance of Staphylococcus aureus isolates to macrolide, lincosamide, streptogramin B, ketolid and linezolid antibiotics in Turkey,” Brazilian Journal of Infectious Diseases, vol. 14, no. 1, pp. 11–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. P. K. Linden, R.C. J. Moellering, C. A. Wood et al., “Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin,” Clinical Infectious Diseases, vol. 33, no. 11, pp. 1816–1823, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Baysallar, A. Kiliç, H. Aydogan, F. Cilli, and L. Doganci, “Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey,” International Journal of Antimicrobial Agents, vol. 23, no. 5, pp. 510–512, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Tunger, Ş. Aydemir, S. Uluer, and F. Cilli, “In vitro activity of linezolid and quinupristin/dalfopristin against Gram-positive cocci,” Indian Journal of Medical Research, vol. 120, no. 6, pp. 546–552, 2004. View at Google Scholar · View at Scopus
  28. G. Bozkurt Yılmaz, H. Kutlu, A. Arslan, and O. Memikoğlu, “A novel antibacterial agent: daptomycin,” Ankara Üniversitesi Tıp Fakültesi Mecmuası, vol. 63, no. 3, pp. 85–88, 2010. View at Google Scholar
  29. L. Oksuz and N. Gurler, “In-vitro susceptibility of methicillin-resistant Staphylococci isolated from clinical samples to newer antibiotics,” ANKEM, vol. 23, no. 2, pp. 71–77, 2009. View at Google Scholar
  30. F. Eksi, E. D. Gayyurhan, and A. Bayram, “Antimicrobial susceptibility of Staphylococcus aureus strains isolated in Gaziantep University Hospital,” ANKEM Dergisi, vol. 22, no. 4, pp. 203–208, 2008. View at Google Scholar